Skip to main content

Table 1 Correlation analysis between serglycin (SRGN) and gene markers of immune cells in skin cutaneous melanoma (SKCM) and SKCM-metastasis

From: The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients

Immune cellGene markerSKCMSKCM-metastasis
CorP valueCorP value
B cellCD 190.364< 0.0010.248< 0.001
CD 790.331< 0.0010.248< 0.001
CD8+ T cellCD8A0.538< 0.0010.510< 0.001
CD8B0.499< 0.0010466< 0.001
NeutrophilsCD66b (CEACAM8)0.0060.890.01100.833
CD11b (ITGAM)0.592< 0.0010.528< 0.001
CCR70.317< 0.0010.267< 0.001
Dendritic cellHLA-DPB10.515< 0.0010.521< 0.001
HLA-DQB10.458< 0.0010.445< 0.001
HLA-DRA0.604< 0.0010.603< 0.001
HLA-DPA10.538< 0.0010.519< 0.001
BDCA-1(CD1C)0.287< 0.0010.267< 0.001
BDCA-4 (NRP1)0.408< 0.0010.326< 0.001
CD11c (ITGAX)0.336< 0.0010.281< 0.001